| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000035536 |
| Receipt No. | R000022621 |
| Official scientific title of the study | Pilot study to explore additional indication of therapeutic hypothermia for neonates |
| Date of disclosure of the study information | 2019/01/14 |
| Last modified on | 2019/01/14 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Pilot study to explore additional indication of therapeutic hypothermia for neonates | |
| Title of the study (Brief title) | Additional indication of hypothermia for neonates | |
| Region |
|
|
| Condition | |||||
| Condition | Neonatal encephalopathy | ||||
| Classification by specialty |
|
||||
| Classification by malignancy | Others | ||||
| Genomic information | NO | ||||
| Objectives | |
| Narrative objectives1 | To assess the safety of moderate systemic hypothermia for 72 hours in neonates who are either slightly (i) less matured (33-35 weeks), (ii) less severely asphyxiated, (iii) mildly encephalopathic, or (iv) older (6-12 hours) than those cooled in previous phase-III trials. |
| Basic objectives2 | Safety |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Death or severe adverse events until hospital discharge |
| Key secondary outcomes | Days on mechanical ventilation
Age at hospital discharge Requirement for tube-feeding at discharge Death or moderate disability (Time Frame: Birth to 18-22 months corrected age) Brain MRI findings (Time Frame: 5-14 days) |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | expanded access |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |||
| No. of arms | 1 | ||
| Purpose of intervention | Treatment | ||
| Type of intervention |
|
||
| Interventions/Control_1 | Induced whole-body cooling with a target core body temoerature of 33.5C for 72 hours | ||
| Interventions/Control_2 | |||
| Interventions/Control_3 | |||
| Interventions/Control_4 | |||
| Interventions/Control_5 | |||
| Interventions/Control_6 | |||
| Interventions/Control_7 | |||
| Interventions/Control_8 | |||
| Interventions/Control_9 | |||
| Interventions/Control_10 | |||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Neonates are first assessed using the standard criteria for therapeutic hypothermia* (Shankaran et al. NEJM 2005).
1. Neonates born at 36 weeks gestation or greater, and body weight >1799g 2. Postnatal age < 6 hours after birth 3. At least one of the following criteria: - Apgar score 0-5 at 10 minutes - Cord or first postnatal blood pH less than 7.0 - Cord or first postnatal blood Base deficit greater than 16 mEq/L - Need for continued resuscitation at least 10 minutes 4. Abnormal neurological exam suggesting the presence of moderate or severe encephalopathy Neonates who meet 3 of 4 criteria are assessed for eligibility using the following entry criteria. Category 1: Neonates < 36 weeks gestation but > 33 0/7 weeks, and/or body weight between 1500g and 1799g. Category 2: Neonates between 6 and 12 hours of birth when cooling is initiated. Category 3: At least one of the following criteria: - Apgar 0-5 at 5 minutes - pH less than 7.1 - Base deficit greater than 10 mEq/L Category 4: Abnormal neurological exam suggesting the presence of mild encephalopathy |
|||
| Key exclusion criteria | Gestational age <33 weeks or body weight <1500g.
Older than 12 hours of birth. Neonates deemed inappropriate for cooling because of critical clinical conditions, such as severe haemorrhagic diathesis, congenital malformations, infection and cardiopulmonary failure. |
|||
| Target sample size | 30 | |||
| Research contact person | |
| Name of lead principal investigator | Osuke Iwata |
| Organization | Kurume University School of Medicine |
| Division name | Dept of Paediatrics |
| Address | 67 Asahimachi, Kurume, Fukuoka, 830-0011 Japan |
| TEL | 0942-35-3311 |
| oiwata@med.kurume-u.ac.jp | |
| Public contact | |
| Name of contact person | Kennosuke Tsuda |
| Organization | Yokohama City University Medical Center |
| Division name | Pediatrics |
| Address | 4-57 Urafune, Minami, Yokohama, Kanagawa, Japan |
| TEL | 045-261-5656 |
| Homepage URL | |
| kentsuda1222@hotmail.co.jp | |
| Sponsor | |
| Institute | Kurume University School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Ministry of Health, Labour and Welfare |
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | Committee on Resuscitation, Japan Society of Perinatal and Neonatal Medicine |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022621 |